Operation Warp Speed Immunitybio

Immunitybios covid 19 vaccine candidate was selected for operation warp speed a national program to accelerate covid 19 vaccine development.

Operation warp speed immunitybio. Operation warp speeds goal is to produce and deliver 300 million doses of safe and effective vaccines with the initial doses available by january 2021 as part of a broader strategy to accelerate the development manufacturing and distribution of covid 19 vaccines therapeutics and diagnostics collectively known as countermeasures. Candidate is the first human adenovirus ad5 vaccine designed to deliver both spike s and nucleocapsid n dna for potential long lasting humoral and cell mediated immunity. In july my administration reached an agreement with pfizer to provide 195 billion. On may 15th almost six months ago to the day we stated the goal of the operation which was to have vaccines and therapeutics available and approved for use in the us.

Clinical stage natural killer cell based therapeutics company nantkwest and immunitybio a privately held immunotherapy company announced immunitybio has been selected to participate in operation. Operation warp speed ows was introduced in april of this year during the coronavirus pandemic. The system was created specifically for operation warp speed and links databases that track every covid 19 vaccine dose from manufacture to patient inoculation. Department of health and human service released a statement that announced operation warp speeds goal is to produce and deliver 300 million doses of safe and effective vaccines with.